{
    "2021-07-04": [
        [
            {
                "time": "",
                "original_text": "股价调整后是否再次上车机会？持续重点推荐药明康德、凯莱英等",
                "features": {
                    "keywords": [
                        "股价调整",
                        "上车机会",
                        "药明康德",
                        "凯莱英"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "杠杆资金爆买1400亿：“最爱”医药 重仓布局了这些股",
                "features": {
                    "keywords": [
                        "杠杆资金",
                        "爆买",
                        "医药",
                        "重仓布局"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}